Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Abacus Medicine A/S

02 4Csl Behring Ag

03 1F. Hoffmann-La Roche, Ltd.

04 3Roche Pharma (Switzerland) Ag

05 3Roche Registration GmbH

06 20Roche Registration Gmbh

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Immunoglobulin

Brand Name : Privigen®

Dosage Form : Infusion Solution

Dosage Strength : 100mg/ml

Packaging :

Approval Date : 22-07-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

02

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Immunoglobulin

Brand Name : Privigen®

Dosage Form : Infusion Solution

Dosage Strength : 100mg/ml

Packaging :

Approval Date : 22-07-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

03

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Immunoglobulin

Brand Name : Privigen®

Dosage Form : Infusion Solution

Dosage Strength : 100mg/ml

Packaging :

Approval Date : 22-07-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

04

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Immunoglobulin

Brand Name : Privigen®

Dosage Form : Infusion Solution

Dosage Strength : 100mg/ml

Packaging :

Approval Date : 22-07-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

05

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg

Packaging :

Approval Date : 21/09/2017

Application Number : 20160430000118

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Injectable Solution

Dosage Strength : 1875mg

Packaging :

Approval Date : 18/01/2024

Application Number : 20221116000072

Regulatory Info : Approved

Registration Country : Sweden

blank

07

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg

Packaging :

Approval Date : 26/08/2019

Application Number : 20180914000090

Regulatory Info : Approved

Registration Country : Sweden

blank

08

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1200mg/20ml

Packaging :

Approval Date : 23/05/2017

Application Number : 66152

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Atezolizumab

Brand Name : Tecentriq

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 840mg/14ml

Packaging :

Approval Date : 23/05/2017

Application Number : 66152

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

Paris Packaging Week
Not Confirmed
arrow
arrow
Paris Packaging Week
Not Confirmed

Atezolizumab

Brand Name : TECENTRIQ subcutaneous

Dosage Form : Injectable Solution

Dosage Strength : 1875mg/15ml

Packaging :

Approval Date : 05/08/2024

Application Number : 69262

Regulatory Info : Allowed

Registration Country : Switzerland

blank